Abstract 2539: MiR-96-5p functions as an oncogenic miRNA by inhibiting apoptosis in hepatocellular carcinoma

N. Iwai(Kyoto Prefectural University of Medicine), Yoshito Ito(Kyoto Prefectural University of Medicine), Osamu Dohi(Kyoto Prefectural University of Medicine), Tomoko Kitaichi(Kyoto Prefectural University of Medicine), Kei Teasaki(Kyoto Prefectural University of Medicine), Yasuyuki Gen(Kyoto Prefectural University of Medicine), Kohichiroh Yasui(Kyoto Prefectural University of Medicine), Akira Tomie(Kyoto Prefectural University of Medicine)
Cancer Research
July 1, 2017
10.1158/1538-7445.am2017-2539
Cited by 1

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy.
|Circulation|1994|235
Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression
|Biochemical and Biophysical Research Communications|1991|189
Isolation of preferentially expressed genes in the kidneys of hypertensive rats.
|Hypertension|1991|168
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma
|Hepatology|2012|154